Clover Health Investments, Corp.
General ticker "CLOV" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $1.7B (TTM average)
Clover Health Investments, Corp. does not follow the US Stock Market performance with the rate: -9.9%.
Estimated limits based on current volatility of 1.7%: low 2.53$, high 2.64$
Factors to consider:
- Total employees count: 570 (+3.3%) as of 2024
- Top business risk factors: Economic downturns and volatility, Regulatory and compliance, Market volatility, Service disruptions, Security breaches
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.56$, 6.09$]
- 2025-12-31 to 2026-12-31 estimated range: [2.30$, 5.30$]
Financial Metrics affecting the CLOV estimates:
- Positive: with PPE of -32.2 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of -3.23
- Positive: -8.75 < Industry operating profit margin (median), % of 1.70
- Positive: 41.86 < Shareholder equity ratio, % of 58.74 <= 63.39
- Positive: Investing cash flow per share per price, % of 0.04 > -0.66
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Inventory ratio change, % of 0.25 <= 0.84
Short-term CLOV quotes
Long-term CLOV plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,096.55MM | $1,260.54MM | $1,371.13MM |
| Operating Expenses | $1,383.22MM | $1,465.87MM | $1,416.88MM |
| Operating Income | $-286.66MM | $-205.33MM | $-45.75MM |
| Non-Operating Income | $32.08MM | $-4.82MM | $-0.52MM |
| Interest Expense | $1.36MM | $0.01MM | $0.00MM |
| Income(Loss) | $-254.58MM | $-210.15MM | $-46.27MM |
| Other Income(Loss) | $0.00MM | $0.00MM | $3.26MM |
| Profit(Loss)* | $-339.57MM | $-213.36MM | $-39.75MM |
| Stockholders Equity | $356.89MM | $286.39MM | $341.14MM |
| Assets | $808.62MM | $570.67MM | $580.74MM |
| Operating Cash Flow | $-203.93MM | $-144.66MM | $34.84MM |
| Capital expenditure | $4.47MM | $0.58MM | $1.56MM |
| Investing Cash Flow | $95.13MM | $140.01MM | $0.56MM |
| Financing Cash Flow | $-4.96MM | $-5.07MM | $-17.36MM |
| Earnings Per Share** | $-0.71 | $-0.44 | $-0.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.